Cepharanthine Ameliorates Pulmonary Fibrosis by Inhibiting the NF-κB/NLRP3 Pathway, Fibroblast-to-Myofibroblast Transition and Inflammation

Pulmonary fibrosis (PF) is one of the sequelae of Corona Virus Disease 2019 (COVID-19), and currently, lung transplantation is the only viable treatment option. Hence, other effective treatments are urgently required. We investigated the therapeutic effects of an approved botanical drug, cepharanthi...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Guangrui Chen, Jian Li, Huimeng Liu, Huiyu Zhou, Mingqiu Liu, Di Liang, Zhiyun Meng, Hui Gan, Zhuona Wu, Xiaoxia Zhu, Peng Han, Taoyun Liu, Ruolan Gu, Shuchen Liu, Guifang Dou
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	MDPI AG 2023-01-01
Reeks:	Molecules
Onderwerpen:	cepharanthine pulmonary fibrosis myofibroblast NF-κB/NLRP3 COVID-19
Online toegang:	https://www.mdpi.com/1420-3049/28/2/753
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!